Company / Operating Margin
REGENXBIO Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-94.6%
FY2025
5-year range
-422.9% / -94.6%
FY2021-FY2025
Trend
+66.2%
vs FY2024
Sector context
#85 of 135
Health Care
What the data says
At -94.6%, REGENXBIO Inc.'s operating margin ranks #85 of 135 in the Health Care sector. Operating Margin has fluctuated over the past 10 years, ranging from -16678.0% in FY2017 to 40.3% in FY2020.
Based on SEC 10-K filings.
-94.6% in FY2025 with a 5-year CAGR of -134.9%.
Improved from -297.1% to -94.6% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +138.6pp
- 5-Year Change
- -134.9pp
- 10-Year Change
- -
Sector benchmark
#85 of 135 in Health CareTop 63% of 135This company -94.6% Sector average -774.4%
▼
+87.8% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 66.2% year-over-year.
- Currently 679.9pp above the Health Care sector average.
- Peak operating margin was recorded in FY2020.
- Lowest operating margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -94.6% | +66.2% |
| FY2024 | -280.0% | +5.8% |
| FY2023 | -297.1% | -27.4% |
| FY2022 | -233.2% | +44.9% |
| FY2021 | -422.9% | -1148.8% |
| FY2020 | 40.3% | +105.5% |
| FY2019 | -730.1% | -1910.9% |
| FY2018 | 40.3% | +100.2% |
| FY2017 | -16678.0% | -27622.8% |
| FY2016 | -60.2% | +23.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026